| Product Name | Zonisamide-13C2-15N |
| Product Code | DA-Z024-i |
| Chemical name | Zonisamide-13C2-15N |
| Synonyms | 1,2-Benzisoxazole-13C2-3-methanesulfonamide-15N; 3-(Sulfamoyl-15N-methyl)-1,2-benzisoxazole-13C2; AD 810-13C2-15N; Aleviatin-13C2-15N; Excegran-13C2-15N; PD 110843-13C2-15N; Zonegran-13C2-15N; |
| Impurity | NA |
| CAS Number | 1188265-58-8 |
| Alternate CAS # | NA |
| Molecular form | C613C2H8N15NO3S |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 215.20 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | aromatics,neurochemicals,pharmaceutical standards,intermediates,fine chemicals,sulphur and selenium compounds,stable isotopes |
| Boiling Point | NA |
| Applications | Zonisamide-13C2-15N is the labeled analogue of Zonisamide, a sulfonamide antiseizure agent; blocks repetitive firing of voltagesensitive sodium channels and reduces voltage-sensitive T-type calcium currents. Heterocyclic methanesulfonide with anticonvulsant properties. The compound is under investigation for potential therapeutic use as an antiepileptic drug. Anticonvulsant. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
